Location out of bounds


All Investigators
Lisa Baumann Kreuziger, MD, MS

Lisa Baumann Kreuziger, MD, MS

Medical Director, Hematology
Associate Investigator

Thrombosis, Hemostasis & Vascular Biology

Associate Investigator
Versiti Blood Research Institute

Associate Professor of Medicine
Medical College of Wisconsin

Contact Us

Lisa Baumann Kreuziger, MD, MS

Medical Director, Hematology
Associate Investigator
Email (414) 937-6826 Fax: (414) 937-6580

  • Research Interests

    Dr. Baumann Kreuziger specializes in non-malignant hematology with an emphasis on patients with clotting and bleeding disorders.  Dr. Baumann Kreuziger is interested in the underlying mechanisms of thrombosis and optimal treatment strategies for patients with thrombosis. 

  • Grant Support
    • INVENT Kickstarter Award
    • ACTIV-4 Clinical Trial Platforms
    • CTSI of Southern Wisconsin Pilot Grant
    • Recipient Epidemiology and Donor Evaluation Study III (REDS III) (PI-Mast)
  • Lab

    Versiti Clinical Trials Research Office:

    Stephanie Jones, MS, CCRC
    Quality and Research Supervisor

    Shannon Broaddrick
    Clinical Research Coordinator

    Neha Jain
    Research Coordinator

  • Publications
    • COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health. Available at https://www.covid19treatmentguidelines.nih.gov/

    • Kreuziger LB, Edgren G, Hauser RG, Zaccaro D, Kiss J, Westlake M, Brambilla D, Mast AE. Red Blood Transfusion Does Not Increase Risk of Venous or Arterial Thrombosis.
      Am J Hematol. 2020 Oct 29. doi: 10.1002/ajh.26038.
    • Rosovsky RP, Sanfilippo KM, Wang TF, Rajan SK, Shah S, Martin KA, Ni Ainle F, Huisman M, Hunt BJ, Khan SR, Kevane B, Lee AYY, McLintok C, Baumann Kreuziger L. Anticoagulation Practice Patterns in COVID‐19: A Global Survey. Research and Practice in Thrombosis and Haemostasis. 2020 Jul 9;4(6):969-83. doi:10.1002/rth2.12414
    • Feih JT, Juul JJ, G Rinka JR, Baumann Kreuziger LM, Pagel PS, Tawil JN. Adequacy of hemostatic resuscitation improves therapeutic efficacy of recombinant activated factor VII and reduces reexploration rate for bleeding in postoperative cardiac surgery patients with refractory hemorrhage. Ann Card Anaesth. 2019 Oct-Dec;22(4):388-393. PMID: 31621674
    • Held N, Jung B, Sommervold L, Sing S, Kreuziger LB.  Patient safety indicator-12 rarely identifies problems with quality of care in perioperative venous thromboembolism. Journal of Hospital Medicine, 2019;14, J Hosp Med. 2019 Nov 20;14:E1-E6. PMID: 31995470
    • Dhakal B, Kreuziger LB, Rein L, et al. Disease burden, complication rates, and health-care costs of heparin-induced thrombocytopenia (HIT) in the USA: a population-based study. The Lancet Haematology. 2018;5(5):e220-e231. PMID: 29703336
    • Moyer GC, Bannow BS, Thornburg C, Rosovsky R, Wang TF, Woller S, Thornhill D, Kreuziger LB. A Survey of Oral Anticoagulant Preferences in the Treatment of Challenging Patient Populations. Clin Appl Thromb Hemost. 2018 Oct 2:1076029618804080.  PMID: 30278766.

This website uses cookies to ensure you get the best experience on our website. Learn more